Atheroprone Flow Activation of the Sterol Regulatory Element Binding Protein 2 and Nod-Like Receptor Protein 3 Inflammasome Mediates Focal Atherosclerosis
- 6 August 2013
- journal article
- editorial
- Published by Wolters Kluwer Health in Circulation
- Vol. 128 (6) , 579-582
Abstract
Athero-prone flow promotes inflammation in endothelial cells, and this process is critical for pathogenesis of many chronic inflammatory conditions such as coronary and carotid artery atherosclerosis, as well as abdominal aortic aneurysm. Signal mediators activated by athero-prone (disturbed) flow that have been described include NF-κB and protein kinase C, which is very different from athero-protective (steady laminar) flow. In this issue a publication from Shyy’s lab shows the critical role of sterol regulatory element binding protein 2 (SREBP2) on athero-prone flow-mediated NLRP3 inflammasome activation. In particular, they showed that athero-prone flow induced both mature form of SREBP2 (SREBP2-N) and SREBP2 mRNA induction, which transcriptionally increase NADPH oxidase 2 (Nox2) and NLRP3 expression, thereby leading to IL-1β expression and endothelial inflammation (Figure 1). In this editorial, we will briefly review the NLRP3 inflammasome and SREBP activation system, which play a key role in modulating athero-prone flow-mediated EC inflammation. We will also discuss the following important questions for the future; the role of local NLRP3 and IL-1β expression, mechanisms for two different types of flow (athero-prone flow vs. athero-protective flow) on SREBP2 activation, and other NLRP3 activators including thioredoxin-interacting protein (TXNIP).Keywords
This publication has 20 references indexed in Scilit:
- SREBP: a novel therapeutic targetActa Biochimica et Biophysica Sinica, 2013
- A role for the NLRP3 inflammasome in metabolic diseases—did Warburg miss inflammation?Nature Immunology, 2012
- The inflammasome: an integrated viewImmunological Reviews, 2011
- Disturbed-Flow-Mediated Vascular Reactive Oxygen Species Induce Endothelial DysfunctionCirculation Journal, 2011
- Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic PlaquesCell Metabolism, 2011
- A role for mitochondria in NLRP3 inflammasome activationNature, 2010
- Central roles of NLRs and inflammasomes in viral infectionNature Reviews Immunology, 2010
- Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetesNature Immunology, 2010
- Shear stress, SIRT1, and vascular homeostasisProceedings of the National Academy of Sciences, 2010
- Thioredoxin-interacting protein links oxidative stress to inflammasome activationNature Immunology, 2009